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by Molecular Breeding of Virus Envelope Genes from Genetically
Divergent Strains
Yan-Yan Ni,a Tanja Opriessnig,b Lei Zhou,a Dianjun Cao,a Yao-Wei Huang,a Patrick G. Halbur,b Xiang-Jin Menga
Department of Biomedical Sciences and Pathobiology, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA,a and Department of Veterinary
Diagnostic and Production Animal Medicine, Iowa State University, Ames, Iowa, USAb
Molecular breeding via DNA shuffling can direct the evolution of viruses with desired traits. By using a positive-strand RNA vi-
rus, porcine reproductive and respiratory syndrome virus (PRRSV), as a model, rapid attenuation of the virus was achieved in
this study by DNA shuffling of the viral envelope genes frommultiple strains. The GP5 envelope genes of 7 genetically divergent
PRRSV strains and the GP5-M genes of 6 different PRRSV strains were molecularly bred by DNA shuffling and iteration of the
process, and the shuffled genes were cloned into the backbone of a DNA-launched PRRSV infectious clone. Two representative
chimeric viruses, DS722 with shuffled GP5 genes and DS5M3 with shuffled GP5-M genes, were rescued and shown to replicate at
a lower level and to form smaller plaques in vitro than their parental virus. An in vivo pathogenicity study revealed that pigs in-
fected with the two chimeric viruses had significant reductions in viral-RNA loads in sera and lungs and in gross andmicro-
scopic lung lesions, indicating attenuation of the chimeric viruses. Furthermore, pigs vaccinated with the chimeric virus DS722,
but not pigs vaccinated with DS5M3, still acquired protection against PRRSV challenge at a level similar to that of the parental
virus. Therefore, this study reveals a unique approach through DNA shuffling of viral envelope genes to attenuate a positive-
strand RNA virus. The results have important implications for future vaccine development and will generate broad general in-
terest in the scientific community in rapidly attenuating other important human and veterinary viruses.
Molecular breeding through DNA shuffling mimics naturalrecombination at an accelerated rate and can direct the evo-
lution of viruses with desired traits (1). In the traditional DNA-
shuffling approach, a set of related parental viral genomes is first
selected and digested with DNase I to create a pool of short DNA
fragments, which is then reassembled by repeated thermocycling
and amplification (2–4). The shuffled chimeric viruses can then be
selected for desired properties (5). Thus far, DNA shuffling has
been mainly used to generate chimeric viruses with novel tissue
tropism or with broader antigenic representation (5–7). To our
knowledge, attenuation of a virus by DNA shuffling has never
been done, although virus attenuation by constructing chimeric
viruses, which is very different from the DNA-shuffling strategy
used in this study, has been reported (8).
In this study, we hypothesize that DNA shuffling of viral genes
that are important virulence determinants could lead to rapid at-
tenuation of viruses. To test our hypothesis, a single-stranded pos-
itive-sense RNA virus, porcine reproductive and respiratory syn-
drome virus (PRRSV), was utilized as a model virus system for
DNA shuffling in this study. PRRSV causes a devastating global
swine disease with immense economic losses (9, 10). It is esti-
mated that the losses associatedwith PRRSV infection are approx-
imately $560.32million per year in theUnited States alone (11). In
2006, “swine high fever disease” outbreaks with a mortality of 20
to 100% caused by a variant strain of PRRSV devastated the swine
industry in China and neighboring countries (12, 13). Rapid de-
velopment of vaccines is critical for the control of such devastating
outbreaks in the future.
PRRSV, a member of the family Arteriviridae, consists of two
distinct genotypes: type 1 (European type) and type 2 (North
American type) (14, 15).Within type 2, there are at least 9 distinct
genetic lineages (16). The PRRSV genome consists of at least 9
overlapping open reading frames (ORFs) (17, 18). TheGP5 andM
proteins, encoded by ORF5 and ORF6, respectively, are the major
structural proteins of PRRSV (19–21). The two proteins form dis-
ulfide-linked heterodimers that bind to heparin sulfate for virus
attachment (22–24). The GP5 protein has a signal peptide at its N
terminus (25) and a glycosylated ectodomain that contains a de-
coy nonneutralizing epitope and a neutralizing epitope (26–30). A
hydrophobic region is located between amino acid residues 60 and
125, followed by a large C-terminal endodomain (31, 32). More
recently, a novel structural protein encoded by ORF5a was iden-
tified, and it may play a role in virus replication (33). GP5 is the
most variable structural protein, with 89 to 94% amino acid se-
quence identity among type 2 PRRSVs (34) but only 51 to 55%
identity between type 1 and 2 PRRSVs (15, 35, 36). Importantly
for this study, it has been shown that one of the major virulence
determinants of PRRSV is located in GP5 (37). Therefore, we se-
lectedGP5 as themain target forDNA shuffling in our attempts to
rapidly attenuate PRRSV. M is a nonglycosylated membrane pro-
tein that likely plays a key role in virus assembly and budding (21).
Since M is closely associated with the function of GP5, we also
included M as the target for DNA shuffling to attenuate PRRSV.
The main objective of this study was to explore whether virus
attenuation can be achieved by molecular breeding of the virus
envelope genes, using PRRSV as a model virus. We molecularly
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bred PRRSV by DNA shuffling of the GP5 genes of 7 and the
GP5-M genes of 6 genetically divergent strains of PRRSV. The
shuffled chimeric viruses were infectious in vitro and, most im-
portantly, attenuated in pigs. This represents the first report of
successful virus attenuation by a DNA-shuffling approach. Fur-
thermore, one shuffled chimeric virus elicited protection against
PRRSV challenge at a level similar to that of its parental virus in
pigs.
MATERIALS AND METHODS
Cells and viruses. BHK-21 and MARC-145 cells were grown at 37°C in
Dulbecco’s minimum essential medium (DMEM) supplemented with
10% fetal bovine serum (FBS) and antibiotics. The North American type
2 PRRSV was systematically classified into 9 genetically distinct lineages
based on the ORF5 gene sequences of 8,624 PRRSV strains (16). To pro-
duce a chimeric virus by molecular breeding, a total of 7 genetically dif-
ferent strains of PRRSV, each representing a distinct genetic lineage or
sublineage in the phylogenetic tree (16), i.e.,MN184B (lineage 1), VR2385
(lineage 5.1), VR2430 (lineage 5.2), S132 (lineage 6), Chinese highly
pathogenic strain JXA1 (lineage 8.7), FL-12 (lineage 8.9), and NADC20
(lineage 9), were selected for DNA shuffling in the study. The genetic
relationship of these selected strains of PRRSV used in DNA shuffling is
shown in a phylogenetic tree (Fig. 1). The GP5 gene sequences of VR2385
and FL-12 were amplified from the infectious clones pIR-VR2385-CA
(12) and pFL-12 (5), respectively. The GP5 gene sequence of strain
VR2430 was amplified from viral stock. The GP5 gene sequences of the
other 4 PRRSV strains (MN184B, S132, JXA1, and NADC20) were com-
mercially synthesized (Genscript) based on the sequences in the GenBank
database.
DNA shuffling of theGP5 andGP5-Mgenes. ForGP5 gene shuffling,
the GP5 genes from seven strains of PRRSV were mixed in equimolar
amounts with a total of 5gDNA and diluted in 50l of 50mMTris-HCl
(pH 7.4) and 10mMMgCl2. Themixture was incubated at 15°C for 2min
FIG 1 Phylogenetic tree based on the GP5 genes of selected PRRSV strains from different genetic lineages of type 2 PRRSV, as reported by Shi et al. (16). The
phylogenetic tree was constructed by using the neighbor-joiningmethod with bootstraps in 1,000 replicates. The number above eachmajor branch indicates the
bootstrap value. The GP5 sequences of the 7 parental strains selected for shuffling in the study are in boldface italics in the tree. Each lineage corresponding to
those reported by Shi et al. (16) is labeled with L and a number beside a vertical line.
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with 0.15 U of DNase I (Sigma). DNA fragments 50 to 150 bp in size were
purified from 2% agarose gels. The purified DNA fragments were subse-
quently added to the Pfu PCR mixture consisting of 1 Pfu buffer, 0.4 mM
each deoxynucleoside triphosphate (dNTP), and 0.06 U Pfu polymerase. A
PCR program without primers (95°C for 4 min; 35 cycles of 95°C for 30 s,
60°C for 30 s, 57°C for 30 s, 54°C for 30 s, 51°C for 30 s, 48°C for 30 s, 45°C for
30 s, 42°C for 30 s, and 72°C for 2 min; and finally, 72°C for 7 min) was
performed to reassemble the digestedDNA fragments. Subsequently, specific
primers flanking the shuffledGP5 gene region, GP5trunc-F (5=-GGGAACA
GCAGCTCAAATTTACAG-3=) and GP5trunc-R (5=-AGGGGTAGCCG
CGGAACCAT-3=), were used to amplify the assembled shuffling prod-
ucts.
Similar approaches were used to shuffle the GP5-M genes from 6 dif-
ferent strains of PRRSV. Unlike GP5 shuffling, strain S132 was not in-
cluded in the GP5-M gene shuffling, since the M gene sequence strain
S132 was not available. Primers GP5F (5=-ATGTTGGGGAAATGCTTGA
CCG-3=) and mfu3=R (5=-GCCGCAATCGGATGAAAGCCTG-3=) were
used to amplify the assembled shuffling products.
Construction of chimeric PRRSV libraries. The shuffled product li-
braries were cloned into a blunt-end vector, pCR-BLUNT, to assess the
quality of the DNA shuffling. The recombination efficiency was analyzed
by sequencing the shuffled genes from 30 randomly selected clones to
delineate crossovers. The nucleotide changes among the parental strains
served as markers to delineate the origin of each fragment between two
proximate crossover sites incorporated in the shuffled product. The frag-
ment between the crossover sites with the same nucleotide pattern as a
particular parental strain was considered to be derived from that parental
strain (Fig. 2 and 3). The shuffled products that contained segments de-
rived from all parental viruses and that had a good number of crossovers
were selected for the study. The GP5 clone DS722 and the GP5-M clone
DS5M3 were ultimately selected from their respective libraries for the
construction of chimeric viruses in the backbone of a DNA-launched
PRRSV infectious clone, pIR-VR2385-CA (38, 39). For cloning purpose,
two flanking fragments amplified from pIR-VR2385-CA containing the
naturally occurring unique restriction sites Acl1 and XbaI, respectively,
were fused to the corresponding shuffled products, and the fusion frag-
ments were cloned into the DNA-launched infectious clone to produce
chimeric viruses containing the shuffled GP5 or GP5-M gene. The amino
acid differences in GP5 among the 7 parental virus strains and the two
chimeric viruses (DS722 and DS5M3) are presented in Fig. 3.
In vitro transfection and immunofluorescence assay (IFA). To res-
cue the infectious chimeric PRRSV from the recombinantDNA-launched
infectious clones, BHK-21 cells at 60% confluence in 6-well plates were
transfected with 3 g of chimeric PRRSV DNA using 8 l of Lipo-
fectamine LTX (Invitrogen) according to themanufacturer’s instructions.
At 48 h posttransfection, the cell culture supernatant was harvested and
FIG 2 Schematic diagram of the shuffled chimeric GP5 gene sequences in two representative chimeras (DS722 andDS5M3). The parental virus sequences of the
GP5 gene for the two chimeras are depicted schematically. The exact boundaries of crossovers are indicated with nucleotide position numbers relative to the GP5
gene. Each pattern represents the sequence derived from an individual parental virus strain. If two patterns are displayed in the same region, it indicates that the
region contains sequences shared by two different parental strains.
FIG 3 Alignment of the GP5 amino acid sequences among the seven parental virus strains and the two chimeras (DS722 and DS5M3). The GP5 sequence of the
backbone virus, VR2385, is shown at the top. Only differences are indicated for other strains.
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passaged ontoMARC-145 cells. Two days later, the cells were washedwith
0.05% phosphate-buffered saline (PBS)-Tween and fixed with 80% ace-
tone (Sigma). The fixed cells were incubated with anti-PRRSV N mono-
clonal antibody SDOW17 (Rural Technologies, Inc.) at 37°C for 1 h. After
washing three times, the cells were then incubated with fluorescein iso-
thiocyanate (FITC)-conjugated goat anti-mouse IgG at 37°C for 1 h. The
stained cells were visualized with a Nikon Eclipse TE300 fluorescence
microscope fitted with a digital camera (Nikon).
Plaque assay.Confluent monolayers of MARC-145 cells cultured in a
6-well platewere infectedwith 10-fold serially diluted viruses (101, 102,
103, 104, and 105). After 1 h of incubation, the inoculumwas removed
and an agar overlay was applied to the cell monolayer. Plaques were
stained with neutral red solution (Sigma) 4 days postinfection at 37°C.
The wells containing 10 to 100 plaques in each plate were selected to
measure the diameter of each plaque. Plaque morphology and size were
compared between the parental virus VR2385 and the two chimeric vi-
ruses.
Growth characterization of the chimeric viruses in vitro. To analyze
the growth characteristics of the chimeric viruses in vitro, a growth curve
was performed in MARC-145 cells, as well as in porcine alveolar macro-
phages (PAMs). The PAMs were obtained by lung lavage of a piglet from
a PRRSV-free university research herd. Confluent monolayers of MARC-
145 or PAMs seeded in 96-well plates were infected with the parental virus
VR2385 and two rescued chimeric viruses (DS722 and DS5M3) at the
samemultiplicity of infection (MOI) of 0.1. Both the infectedMARC-145
cells and PAMs were harvested at 6, 12, 24, 36, 48, 60, and 72 h postinfec-
tion (p.i.), and an additional time point at 84 h p.i. was added for the
infected MARC-145 cells. The titers of virus harvested at different time
points were determined by IFA inMARC-145 cells and quantified as 50%
tissue culture infective doses (TCID50)/ml. All in vitro experiments were
performed in triplicate.
Pathogenicity study of the two chimeric viruses in specific-patho-
gen-free (SPF) pigs. To determine and compare the virulences of the two
chimeric viruses and the parental virus in pigs, we used a nursery pig
respiratory disease model to assess the pathogenicity of PRRSV, since the
nursery pig model has been widely used worldwide for evaluating PRRSV
virulence and vaccine efficacy (40–44). A total of 24 SPF pigs at 3 weeks of
age were divided into 4 groups of 6 each and intramuscularly inoculated
with the respective viruses, as shown in Table 1. All six pigs from each
group were necropsied at 14 days p.i. At necropsy, the lung tissues were
collected from each pig for histological examination and for quantifica-
tion of viral-RNA loads.
Challenge-and-protection study in SPF pigs vaccinatedwith chime-
ric viruses. A total of 72 SPF pigs at 3 weeks of age were divided into 8
groups of 9 pigs per group and vaccinated as shown in Table 2. At 35 days
postvaccination (p.v.), pigs in each group were challenged with either the
parental VR2385 virus or a heterologous NADC20 virus (Table 2). At 14
days postchallenge (p.c.), all pigs were necropsied, and gross pathological
lung lesions were recorded and scored (35). Lung tissues were also col-
lected for histological examination and viral-RNA load quantification.
Real-time PCR to quantify viral-RNA loads in sera and lung tissues
of pigs. To quantify viral-RNA loads in lung tissues, samples of lung
tissues (500 mg) collected at each necropsy were homogenized in 10%
(wt/vol) sterile PBS. The homogenates were centrifuged at 3,000 rpm at
4°C for 15 min, and the supernatants were used for quantification of
PRRSVRNA. Total RNAs were extracted fromweekly serum samples and
homogenates of lung tissues using TRI Reagent (MRC) and used to syn-
thesize cDNA using a Superscript II kit (Invitrogen). PRRSV genomes
were quantified using a SYBR green-based quantitative PCR (qPCR). A
pair of primers (forward primer, 5=-TTAAATATGCCAAATAACAACG
G-3=; reverse primer, 5=-TGCCTCTGGACTGGTT-3=) were designed
based on the conserved region in the nucleocapsid gene using Beacon
software. The qPCR assay was conducted in a CFX96 real-time (RT) PCR
system (Bio-Rad). The reactions were performed in a 20-l PCR volume
containing 10 l SsoFast EvaGreen Supermix (Bio-Rad), 0.5 l of each
primer (10 M), 5 l of the template cDNA, and 4 l of nuclease-free
water. The cycling parameters included an initial denaturation at 95°C for
10min, followed by 39 cycles of denaturation at 95°C for 10 s and anneal-
ing and extension at 58°C for 20 s. Dissociation curve analysis was per-
formed using the instrument’s default setting immediately after each PCR
run. Each reaction was measured in triplicate.
Necropsy and gross pathology evaluation. All pigs were humanely
euthanized by intravenous pentobarbital overdose (Fatal-Plus; Vortech
Pharmaceutical, Ltd., Dearborn, MI). Veterinary pathologists were
blinded to the treatment status of the pigs for evaluation of gross lung
lesions. The total amount of lung affected by pneumonia (0 to 100%of the
lung affected by grossly visible pneumonia) was recorded for each pig at
necropsy while blinded to the treatment status, as described previously
(35). Briefly, the scoring system is based on the approximate volume that
each lung lobe contributes to the entire lung: the right cranial lobe, right
middle lobe, cranial part of the left cranial lobe, and caudal part of the left
cranial lobe contribute 10% each to the total lung volume; the accessory
lobe contributes 5%; and the right and left caudal lobes contribute 27.5%
each (35). Five defined sections of lungs (35) were collected, immediately
immersed in 10% neutral buffered formalin, and routinely processed for
histological examination. In addition, fresh lung tissues were collected
separately and immediately stored at80°C for virological testing.
Histopathology evaluation.Microscopic lung lesions were evaluated
independently by two veterinary pathologists (T.O. and P.G.H.) blinded
to the treatment status. Lung sections were scored for the presence and
severity of interstitial pneumonia, ranging from 0 to 6 (0, normal; 1, mild
multifocal; 2, mild diffuse; 3, moderate multifocal; 4, moderate diffuse; 5,
severe multifocal; 6, severe diffuse) (35). If the results obtained by the two
pathologists on a certain tissue differed, the mean of the two scores was
used.
Statistical analyses. A two-tailed Student’s t test was used to evaluate
the differences (P 0.05) between the samples in the two groups for both
in vitro and in vivo studies. The data were analyzed using GraphPad Prism
(version 5.0).
Nucleotide sequence accession numbers. The GP5 sequences of the
parental virus strains and the two shuffled chimeras were deposited in the
TABLE 1 Experimental design for comparative pathogenicity study to
determine virulence of shuffled chimeric viruses in pigs
Group
Inoculum
(2 105 TCID50/pig) No. of pigs
Necropsy at 14 days
postinoculation
(no. of pigs)
A Parental VR2385 6 6
B Chimera DS722 6 6
C Chimera DS5M3 6 6
D DMEM control 6 6
TABLE 2 PRRSV challenge and protection study in pigs vaccinated with
attenuated chimeric viruses or with parental virus
Group
No. of
pigs
Vaccination at
day 0 (2 105
TCID50/pig)
Challenge virus
at 35 days
postvaccinationa
Necropsy at 14 days
postchallenge (no.
of pigs)
1 9 Parental VR2385 VR2385 8b
2 9 Parental VR2385 NADC20 9
3 9 Chimera DS722 VR2385 9
4 9 Chimera DS722 NADC20 9
5 9 Chimera DS5M3 VR2385 9
6 9 Chimera DS5M3 NADC20 9
7 9 DMEM control VR2385 9
8 9 DMEM control NADC20 9
a The challenge virus dose for all viruses was 2 105 TCID50/pig.
b One pig died from an unrelated cause before the challenge.
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GenBank database under accession numbers JX044140 (VR2385),
JX050225 (VR2430), AY545985 (FL-12), DQ176020 (MN184B),
EF112445 (JXA1), JX069953 (NADC20), JX069952 (S132), JX044138
(DS722), and JX044139 (DS5M3).
RESULTS
Generation of infectious chimeric viruses containingwell-shuf-
fled GP5 or GP5-M genes from 7 and 6 genetically distinct
strains of PRRSV, respectively.To generate GP5-shuffled chime-
ric viruses with good growth fitness, we excluded 96 nucleotides
(nt) from the 5= end of the GP5 gene, including the signal peptide
sequence and the 16-nt region overlapping the M gene, as well as
the junction site sequence from 23 to 18 nt upstream of the M
gene, for DNA shuffling of the GP5 genes. The resulting 468-nt
GP5 genes from seven PRRSV strains, each representing a distinct
genetic lineage or sublineage (16) (Fig. 1), were shuffled with
DNase I digestion, followed by PCRwithout primers for reassem-
bly. A PCR product consisting of reassembled shuffled products
with an expected size of 468 bp was obtained after a second PCR
with specific primers flanking the shuffled region. To generate
chimeras containing segments derived from all seven parental vi-
ral strains, the shuffling process was iterated by using the shuffled
DNA pool from the first-round shuffling as the parents (2, 4).
Sequence analyses of 30 representative clones that were ran-
domly selected from the shuffled library revealed that they all con-
tained chimeric GP5 sequences, but only two clones contained
sequences from all 7 parental viruses. The numbers of crossovers
ranged from 8 to 12 in the shuffled GP5 gene products. The GP5
clone DS722, which contains segments derived from all seven pa-
rental viral sequences with 12 crossovers, was selected from the
shuffled library (Fig. 2) and cloned into the backbone of a DNA-
launched PRRSV infectious clone (39). The resulting chimeric
virus, DS722, containing the shuffled GP5 genes from 7 different
strains of PRRSV was successfully rescued from transfected cells
(Fig. 4B).
Similar approaches were used to shuffle the region spanning
theGP5-Mgenes of 6 distinct strains of PRRSV. Sequence analyses
of 10 representative clones that were randomly selected from the
shuffled library revealed that all contained the chimeric GP5 se-
quences, and 6 of the 10 clones contained sequences derived from
all 6 parental viruses. The numbers of crossovers ranged from 12
to 22 in the shuffled GP5 gene products. The chimeric GP5-M
clone DS5M3, containing segments derived from all 6 parental
viral sequenceswith 18 crossovers (Fig. 2), was selected and cloned
into the backbone of the DNA-launched PRRSV infectious clone.
The GP5-M chimeric virus DS5M3 was successfully rescued from
transfected cells (Fig. 4C). The amino acid differences in GP5
among the parental and shuffled viruses are indicated in Fig. 3.
The two chimeric viruses replicated at a lower level, both in
MARC-145 cells and in PAMs, and formed smaller plaques in
MARC-145 cells than the parental virus. To characterize and
compare the growth characteristics between the two chimeric vi-
ruses (DS722 and DS5M3) and the parental virus (VR2385), the
growth kinetics of the three viruses were analyzed by infection of
MARC-145 cells or PAMs with the respective virus at the same
MOI of 0.1. The infectious-virus titers were determined at differ-
ent times p.i. The results showed that, in MARC-145 cells, the
chimeric virus DS722 replicated to significantly lower levels than
the parental virus, VR2385, at all time points except 60 and 84 h
p.i., whereas the chimeric virus DS5M3 also displayed a signifi-
cantly lower level of replication than VR2385 (Fig. 5A). In PAMs,
the chimeric virus DS722 replicated to significantly lower levels
than the parental virus, VR2385, at all time points except 6 and 12
h p.i. The other chimeric virus, DS5M3, displayed a significantly
lower level of replication at all time points than VR2385 (Fig. 5B).
Both chimeric viruses and the parental virus developed plaques
within 4 days p.i. in MARC-145 cells. However, the diameters of
the plaques formed by the two chimeric viruses were significantly
smaller than that formed by the parental virus (P  0.001) (Fig.
5C), further indicating that the chimeric viruses had a lower
growth capacity in vitro than the parental virus.
Both chimeric viruses (DS722 and DS5M3) were attenuated
in pigs. The pathogenicity study revealed that pigs infected with
the chimera DS5M3 had significantly lower serum viral-RNA
loads than pigs infected with the parental virus, VR2385, at both 7
(P  0.02) (Fig. 6A) and 14 (Fig. 6B) days p.i. (P  0.0009).
Similarly, the serum samples from pigs infected with chimera
DS722 also had lower viral-RNA loads than pigs infected with
the parental virus at both 7 and 14 days p.i., and the difference
was significant at 7 days p.i. (P 0.03) (Fig. 6A), but not at 14
days p.i., although most sera from the DS722 group displayed
viral-RNA loads lower than those from the VR2385 group at 14
days p.i. (Fig. 6B).
Similarly, pigs infected with the chimera DS5M3 had signifi-
cantly lower viral-RNA loads (P 0.0001) in the lung tissues than
pigs infected with VR2385. The pigs infected with the chimera
DS722 also had a lower viral load in the lung than pigs infected
with the parental virus, although the difference was not significant
(Fig. 6C).
Macroscopic lung lesions were generally absent or mild in pigs
inoculated with DMEM and with the two chimeras, DS5M3 and
DS722 (Fig. 7A). In pigs infected with the parental VR2385 virus,
visible gross lung lesions were more pronounced and affected an
average of 42% of the lung surfaces (Fig. 7A). The mean scores of
FIG 4 Rescue and in vitro passages of the shuffled chimeric viruses DS722 and
DS5M3. (A) IFA confirmation using anti-PRRSV Nmonoclonal antibody for
the rescue of the parental virus, VR2385, in MARC-145 cells infected with the
supernatant of BHK-21 cells transfected with a DNA-launched PRRSV infec-
tious clone, pIR-VR2385-CA. (B and C) IFA confirmation of the rescue of the
chimeric viruses DS722 (B) and DS5M3 (C) in MARC-145 cells infected with
the supernatant of BHK-21 cells transfected with shuffled clones pIR-DS722
and pIR-DS5M3, respectively. (D) There was no fluorescent signal in the
MARC-145 cells infected with the supernatant of BHK-21 cells transfected
with a plasmid containing a defective PRRSV VR2385 backbone.
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the gross lung lesions in pigs inoculated with the two chimeric
viruses, DS722 (P  0.005) and DS5M3 (P  0.0001), were sig-
nificantly lower than that of the pigs inoculated with the parental
virus, VR2385 (Fig. 7A). The mean scores of the histological lung
lesions in pigs infected with the chimeric viruses DS722 (P 
0.0002) and DS5M3 (P  0.0001) were significantly lower than
that in pigs infected by the parental VR2385 virus (Fig. 7B).
ChimeraDS722, but not chimeraDS5M3, elicited protection
in pigs against PRRSV challenge at a level similar to that in the
parental virus. To investigate whether the two attenuated chime-
ras could still elicit protection against PRRSV, pigs were first vac-
cinated with the parental virus, VR2385; the chimera DS722 or
DS5M3; orDMEM(Table 2). Eight or nine vaccinated pigs each in
groups 1, 3, 5, and 7 were then challenged at 35 days p.v. with the
parental VR2385 virus (lineage 5). Nine vaccinated pigs each in
groups 2, 4, 6, and 8 were challenged at 35 days p.v. with a heter-
ologous NADC20 virus (lineage 9) (Table 2). At the time of chal-
lenge at 35 days p.v., viremia was not detected in any of the pigs by
RT-PCR. All pigs were necropsied at 14 days p.c.
For the pigs challenged with the parental strain VR2385, at 7
days p.c., the serum viral-RNA loads significantly decreased in
pigs vaccinated with VR2385 (P  0.005) or with the chimera
DS722 (P  0.003), but not in pigs vaccinated with the chimera
DS5M3, compared to group 7 control pigs (Fig. 8A). Similarly, at
14 days p.c., the serum viral-RNA loads significantly decreased in
pigs that were vaccinated with VR2385 (P  0.01) or with the
chimera DS722 (P  0.01), but not in pigs vaccinated with the
chimera DS5M3, compared to group 7 control pigs (Fig. 8B).
The reduction of the serum viral-RNA loads against challenges
with parental VR2385 and heterologous NADC20 in pigs vacci-
nated with the chimera DS722 was similar to that in pigs vacci-
nated with the parental virus, VR2385, at both 7 and 14 days p.c.
(Fig. 8A and B). The viral-RNA loads in the lung tissues at 14 days
p.c. were significantly decreased in pigs vaccinatedwith the paren-
tal virus, VR2385 (P  0.002), or with the chimera DS722 (P 
0.0001), but not in pigs vaccinatedwith the chimeraDS5M3, com-
pared to group 7 control pigs (Fig. 8C). The pigs vaccinated with
the chimera DS722 displayed significantly lower viral-RNA loads
in the lung tissues than the pigs vaccinated with VR2385 (Fig. 8C).
For pigs challenged with a heterologous NADC20 strain, at 7
days p.c., the serum viral-RNA loads were significantly lower in
pigs vaccinated with the parental virus (P  0.0002) or with the
two chimeras DS722 (P 0.0002) and DS5M3 (P 0.02) than in
group 8 controls (Fig. 8A). Similarly, at 14 days p.c., there were
significant reductions in the serum viral-RNA loads in pigs vacci-
nated with the parental virus, VR2385 (P  0.01), or with two
FIG 6 Viral-RNA loads in serum samples and lung tissues in the comparative-pathogenicity study from pigs infected with the parental virus, VR2385, and
chimeric virus DS722 or DS5M3 or inoculated with DMEM (negative control) at 7 and 14 days p.i., respectively. (A) PRRSV viral-RNA loads in serum samples
at 7 days p.i. (B) PRRSV viral-RNA loads in serum samples at 14 days p.i. (C) Viral-RNA loads in the lung collected during necropsy. Significant differences are
indicated with asterisks (*, P 0.05; ***, P 0.001). In all three panels, the numbers within circles along the x axis indicate the numbers of animals in each group
that tested negative for viral RNA.
FIG 5 In vitro growth kinetics and plaque morphology of the shuffled chimeric viruses DS722 and DS5M3. (A) Growth kinetics of the parental virus, VR2385,
and the two chimeric viruses (DS722 and DS5M3) in MARC-145 cells. The virus infectious titers (TCID50/ml) were determined at the indicated time points
postinfection. * and #, statistically significant difference between the chimeric viruses and the parental virus at that time point. The experiments were performed
in triplicate, and the error bars indicate standard errors. (B) In vitro growth kinetics of the chimeras DS722 and DS5M3 on PAMs. The virus infectious titers
(TCID50/ml) were determined at the indicated time points postinfection. * and #, statistically significant difference between each of the chimeric viruses and the
parental virus at that time point. The experiments were performed in triplicate, and the error bars indicate standard errors. (C) Plaque morphologies and
diameters of the parental virus VR2385 and chimeric viruses DS722 and DS5M3 on MARC-145 cells.
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chimeras, DS722 (P 0.03) and DS5M3 (P 0.02), compared to
group 8 control pigs (Fig. 8B). Also, the viral-RNA loads in the
lung tissues at 14 days p.c. were significantly reduced in pigs vac-
cinated with the parental virus, VR2385 (P 0.002), and with the
chimera DS722 (P  0.01), but not in pigs vaccinated with the
chimera DS5M3, compared to group 8 control pigs (Fig. 8C).
The reduction of viral-RNA loads in the lung tissues of pigs vacci-
nated with the chimera DS722 was similar to that in pigs vaccinated
with the parental virus, VR2385, at both 7 and 14 days p.c. (Fig. 8C).
At necropsy, the average scores of both macroscopic and mi-
croscopic lung lesions in pigs vaccinated with two chimeras
(groups 3, 4, 5, and 6) were significantly lower than those in the
control pigs in groups 7 and 8 (Fig. 9A and B). The protection,
based on the macroscopic and microscopic lung lesions, was
much more effective in the DS722-vaccinated pigs than in
DS5M3-vaccinated pigs. The average scores of gross and micro-
scopic lung lesions in DS722-vaccinated pigs were mostly similar
to those in VR2385-vaccinated pigs, although the scores in
DS5M3-vaccinated pigs were significantly higher than those in
VR2385-vaccinated pigs (Fig. 9).
Both chimeras DS722 and DS5M3 were stable in vivo. The
shuffled genes of chimeric viruses DS722 and DS5M3 recovered
from the sera of pigs in the respective groups at 14 days p.i. were
amplified by RT-PCR and sequenced. Sequence analyses revealed
that the sequences of the recovered viruses were the same as those
of the original virus inocula, indicating the genetic stability of
these two chimeric viruses in animals.
DISCUSSION
Molecular breeding through DNA shuffling can direct the evolu-
tion of viruses in vitro and select new strains with desired traits. To
determine if molecular breeding of virus envelope genes that are
important virulence determinants can produce an attenuated vi-
rus that retains its protective ability against challenge, we bred the
GP5 genes of 7 and the GP5-M genes of 6 genetically distinct
strains of PRRSV by DNA shuffling and iteration of the shuffling
process. The application of iteration of theDNA-shuffling process
increased the chances to incorporate all parental viral genes into
the small GP5 region (2, 4). Two representative chimeric viruses, a
GP5 chimera, DS722, and a GP5-M chimera, DS5M3, were res-
cued and selected for further studies. Although both chimeras
were infectious in vitro, they both displayed a lower level of virus
replication in both MARC-145 cells and PAMs. In addition, both
chimeric viruses formed smaller plaques in MARC-145 cells than
the parental virus, indicating that the two shuffled chimeric vi-
ruses exhibited an attenuated phenotype in vitro.
FIG 7 Macroscopic and microscopic lesions in the lung tissues from pigs experimentally infected with the parental virus, VR2385, and the two chimeric viruses
DS722 and DS5M3 during necropsy at 14 days p.i. (A) Macroscopic-lesion scores of lung tissues at 14 days p.i. from the 6 pigs infected with the parental virus,
VR2385, and the chimeric viruses DS722 and DS5M3 or inoculated with DMEM (negative control). (B) Microscopic-lesion scores of lung tissues at 14 days p.i.
Significant differences are indicated with asterisks (**, P 0.01; ***, P 0.001).
FIG 8 Viral-RNA loads in serum samples at 7 and 14 days and in lung tissues at 14 days p.c. from the challenge/protection study in pigs vaccinated with the
chimeric viruses (DS722 or DS5M3), followed by challenge. (A) PRRSV viral-RNA loads in serum samples from pigs at 7 days p.c. with a homologous PRRSV,
VR2385, or a heterologous PRRSV, NADC20. (B) PRRSV viral-RNA loads in serum samples from pigs at 14 days p.c. with PRRSV VR2385 or NADC20. (C)
PRRSV viral-RNA loads in the lung tissues from pigs at 14 days p.c. Significant differences are indicated with asterisks (*, P 0.05; **, P 0.01; ***, P 0.001).
In all three panels, the numbers within circles along the x axis indicate the numbers of animals in each group that tested negative for serum viral RNA.
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To further determine whether DNA shuffling of the GP5 or
GP5-Mgene altered virus virulence in vivo, we conducted a patho-
genicity study (Table 1) and showed that there was a significant
reduction in both the macroscopic- and microscopic-lung-lesion
scores in pigs infected with the two chimeras compared to those
infected with the parental virus. Significant reductions in viral-
RNA loads in sera and lung tissues were also found in pigs infected
with the chimera DS5M3. The in vitro growth and the in vivo
pathogenicity studies indicated that both chimeras were attenu-
ated. Therefore, rapid attenuation of PRRSV was achieved in this
study by shuffling of the virulence determinant GP5 genes from
multiple genetically divergent virus strains. It is important to note
that GP5 is not the sole gene responsible for PRRSV virulence
(37), and thus, DNA shuffling of other PRRSV genes also involved
in virulence in the future may further improve virus attenuation.
Nevertheless, this unique DNA-shuffling approach to attenuate a
virus is more advantageous than many other traditional reverse-
genetics system approaches in that DNA shufflingmimics the nat-
ural evolution of viruses and does not require an understanding of
the functionality of the shuffling regions; rather, the approach
relies on functional screening for the desired traits of the shuffled
viruses, such as the attenuation phenotype in this study.
Since the two chimeric viruses displayed an attenuated pheno-
type in vivo, we next evaluated whether the chimeric viruses could
still induce protection against PRRSV challenge. Eight groups of
pigs were first vaccinated with the parental virus, VR2385; the two
chimeras; or DMEM (Table 2). At 35 days p.c., pigs in each group
were challenged with a homologous (lineage 5) or a heterologous
(lineage 9) PRRSV. The results revealed that the chimera DS722
still elicited solid protection against challenges by both homolo-
gous and heterologous PRRSV strains. However, the GP5-M-
shuffled chimeric virus DS5M3 did not induce a sufficient level of
protection, even though there was a significant reduction in mac-
roscopic- and microscopic-lung-lesion scores. Thus, the GP5-
shuffled chimeric virus DS722 still retains its ability to elicit pro-
tection against PRRSV, suggesting that the DNA shuffling of the
virulence determinant gene attenuated the virus but did not im-
pair the ability of the shuffled virus to elicit protection.
We had initially thought that the GP5-M chimera DS5M3
would also retain its ability to elicit protection, since GP5 and M
form heterodimers (45). The observed poor protection of the chi-
mera DS5M3 was likely due to the low replication fitness of the
chimera in vivo, since only low levels of chimeraDS5M3 viral RNA
were detected in both sera and lung tissues in the pathogenicity
study. The GP5-M DNA shuffling included some critical regions
for virus replication, such as the GP5 signal peptide sequence and
the overlapping region, and thus, shuffling of these critical regions
likely affected the viral replication efficiency in vivo, leading to
overattenuation of the chimera DS5M3 and thus poor protection
compared to the GP5 chimera, DS722. In addition, glycosylation
of the major envelope protein GP5 is known to play an important
role in PRRSV virulence (46). For the chimera DS5M3, it appears
that DNA shuffling resulted in the loss of an important glycosyla-
tion site at amino acid position 34 of the chimera compared to its
parental virus, VR2385 (Fig. 3), and this might contribute to the
virus attenuation phenotype of the chimera (46). Although the
exact mechanism of attenuation by DNA shuffling remains un-
known, the attenuation phenotype of the shuffled viruses may be
attributed to the altered growth efficiency of the chimeric viruses.
In addition, potential conformational changes of the shuffledGP5
in the chimeras may alter its interactions with other viral proteins
or host cells, leading to attenuation (6).
In conclusion, attenuation of a virus by DNA shuffling of its
envelope genes was demonstrated for the first time. We success-
fully produced two chimeric viruses that displayed attenuated
phenotypes both in vitro and in vivo by shuffling the GP5 gene
containing major virulence determinants and the GP5-M genes.
The attenuated shuffled virus DS722 still induced protection sim-
ilar to that of its parental virus against PRRSV infection. Although
development of an improved PRRSV vaccine with better protec-
tion was not within the scope of the present study, it is logical to
speculate that further shuffling of other structural genes, such as
GP3 and GP4, which are relevant for neutralizing activities, in the
future may lead to the generation of a more broadly protective
PRRSVmodified live-attenuated vaccine. Therefore, attenuation of a
positive-strandRNAvirus byDNAshuffling, as demonstrated in this
study, has important implications for potential future vaccine devel-
opment and thus is of broad general interest to the scientific commu-
nity, as this approach of rapid virus attenuation can be easily applied
to other important human and veterinary viruses.
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